Trial Profile
Phase II Trial of Neoadjuvant Compound 121564 Plus Platinum Doublet Chemotherapy in Non-Small Cell Lung Cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2022
Price :
$35
*
At a glance
- Drugs 121564 (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 11 Dec 2018 New trial record